Rate My Professor Jennifer Martin

Professor Jennifer Martin is the Chair of Clinical Pharmacology and Head of Discipline of Medicine in the School of Medicine and Public Health at the University of Newcastle, Australia. A dual-trained clinical pharmacologist and general physician practicing in the Hunter New England Local Health District, she earned her MBChB from the University of Otago, an MA (Oxon) from the University of Oxford as a Rhodes Scholar studying Philosophy, Politics, and Economics with a focus on health economics, and a PhD from Monash University in 2005 examining innate immunity and heart failure pathophysiology in type 2 diabetes. She completed a postdoctoral fellowship at the Walter and Eliza Hall Institute on macrophage function in high-fat diets and previously served as Head of Southside Clinical School at the University of Queensland, where she contributed to revising medical curricula. Martin assumed her position at Newcastle in 2013.

She directs the Centre for Drug Repurposing and Medicines Research and the NHMRC-funded Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), leading the largest international medicinal cannabis trial enabling access for advanced cancer patients and serving as lead investigator on a $1.96 million Cancer Council NSW grant for personalised chemotherapy dosing systems. Her research specializations include clinical pharmacology, therapeutic drug monitoring, drug repurposing, and optimised dosing in cancer therapies. Key publications encompass 'Reducing inappropriate polypharmacy: the process of deprescribing' (JAMA Internal Medicine, 2015), 'Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis' (Breast Cancer Research and Treatment, 2010), and 'Therapeutic drug monitoring of antimicrobials' (British Journal of Clinical Pharmacology, 2012). An elected Fellow of the Australian Academy of Health and Medical Sciences since 2020, she is President of the Royal Australasian College of Physicians as of 2024, following her role as President-Elect, and contributes to health policy committees and serves as Editor-in-Chief of Pharmacology Research & Perspectives.